These innovative therapies , Retatrutide, represent a remarkable advancement in treating type 2 diabetes and potentially other disorders. These drugs are classified as GLP-1 pathway activators , indicating these substances to mimic the body's GLP-1 peptide, enhancing metabolic secretion and suppr